Documents & Publications
Expansion of Cancer Biomarker Testing
With the implementation of next generation sequencing (NGS) and newly available funding from OH-CCO, we are currently expanding our biomarker testing for non-small cell lung cancer, colorectal cancer, small bowel cancer, cutaneous/mucosal melanoma, uveal melanoma, and squamous cell carcinoma of the head and neck.
Please download the PDF for full details.
June 4, 2021Download
Prothrombin Time (PT) Reagent Lot Number Change
The Division of Hematological Pathology will be changing the lot number of the Thromborel S (Prothrombin Time) reagent and as a result the current reference range will change.
Please download the PDF for full details.
June 17, 2020Download
Lipid Profile Update
In keeping with current guidelines on management of dyslipidemia [1, 2], Lipid Profile will be updated as follows, effective May 28, 2020.
Please download the PDF for full details.
May 25, 2020Download
COVID-19 diagnostic testing
Effective March 12, 2020, COVID-19 testing has been available at Shared Hospital Laboratory, our Microbiology service provider.
Please download the PDF for full details.
March 23, 2020Download
Restriction on Repeat Testing of HbA1c
The Medical Advisory Committee has approved a restriction on repeat testing of HbA1c.
Please download the PDF for full details.
March 8, 2020Download
